Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110) by Stewart, J.P. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterization of murine gammaherpesvirus 68 glycoprotein B
(gB) homolog: similarity to Epstein-Barr virus gB (gp110)
Citation for published version:
Stewart, JP, Janjua, NJ, Sunil-Chandra, NP, Nash, A & Arrand, JR 1994, 'Characterization of murine
gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110)' Journal of
Virology, vol 68, no. 10, pp. 6496-6504.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Journal of Virology
Publisher Rights Statement:
Copyright  1994, American Society for Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
JOURNAL OF VIROLOGY, OCt. 1994, p. 6496-6504 Vol. 68, No. 10
0022-538X/94/$04.00+0
Copyright C 1994, American Society for Microbiology
Characterization of Murine Gammaherpesvirus 68
Glycoprotein B (gB) Homolog: Similarity to
Epstein-Barr Virus gB (gpllO)
J. P. STEWART,1* N. J. JANJUA,' N. P. SUNIL-CHANDRA,2 A. A. NASH,2 AND J. R. ARRAND'
CRC Department of Molecular Biology, Paterson Institute for Cancer Research, Christie Hospital,
Manchester M20 9BX, 1 and Division of Immunology, Department of Pathology,
University of Cambridge, Cambridge CB2 JQp,2 United Kingdom
Received 24 May 1994/Accepted 7 July 1994
Murine gammaherpesvirus 68 (MHV-68) is a natural pathogen of murid rodents and displays similar
pathobiological characteristics to those of the human gammaherpesvirus Epstein-Barr virus (EBV). However,
in contrast to EBV, MHV-68 will replicate in epithelial cells in vitro. It has therefore been proposed that
MHV-68 may be of use as a model for the study of gammaherpesviruses, EBV in particular, both in vitro and
in vivo. The EBV homolog of herpes simplex virus glycoprotein B (gB), termed gpllO, is somewhat unusual
compared with those of many other herpesviruses. We therefore decided to characterize the homolog of gB
encoded by MHV-68 (termed MHV gB) to observe the properties of a gammaherpesvirus gB produced in
epithelial cells and also to test the relatedness of MHV-68 and EBV. The MHV gB-coding sequence was
determined from cloned DNA. The predicted amino acid sequence shared closest homology with gammaher-
pesvirus gB homologs. Biochemical analysis showed that MHV gB was a glycoprotein with a molecular weight
of 105,000. However, the glycans were of the N-linked, high-mannose type, indicating retention in the
endoplasmic reticulum. In line with this, MHV gB was localized to the cytoplasm and nuclear margins of
infected cells but was not detected on the cell surface or in virions. Additionally, anti-MHV gB antisera were
nonneutralizing. Thus, the MHV gB was unlike many other herpesvirus gBs but was extremely similar to the
EBV gB. This highlights the close relationship between MHV-68 and EBV and underlines the potential of
MHV-68 as a model for EBV in epithelial cells both in vitro and in vivo.
Murine herpesvirus 68 (MHV-68) was isolated from a
free-living murid rodent (3). Genetic and biological analyses
have revealed that MHV-68 is closely related to the gamma-
herpesviruses, in particular the Epstein-Barr virus (EBV).
Thus, a limited amount of MHV-68 sequence information has
revealed a number of genes with strong homology to gamma-
herpesvirus genes and has shown that these genes lie in a
similar position in the genome to those of EBV and herpesvi-
rus saimiri (10, 11). After initial infection in vivo, MHV-68
replicates in epithelial cells and then spreads into B lympho-
cytes, where the virus becomes latent and persists (35-37). This
initial infection is also controlled by a CD8 T-cell response
(12). In addition to its B-cell tropism in vivo, MHV-68 infects
and persists in B cells in vitro, where, like EBV, the genome
persists in a mixture of episomal and linear forms (37). In
contrast to EBV, however, MHV-68 will readily replicate in
epithelial cells in vitro and is therefore an attractive model for
analyzing the molecular and biochemical properties of gam-
maherpesviruses in infected cells.
Glycoprotein B (gB) is the most highly conserved glycopro-
tein between herpesviruses, with the herpes simplex virus
(HSV) gB being the prototype (30). HSV gB is a large
glycoprotein which is a component of virus particles and can
also be found on the nuclear, cytoplasmic, and plasma mem-
branes of infected cells (16, 26). It has a large external domain
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which is glycosylated, a transmembrane domain which acts as a
membrane anchor, and a shorter cytoplasmic domain (4, 17,
25). There are two forms of HSV gB in the cell: a precursor
form on which the glycosylation is immature and a fully
processed form (19, 39) which is present in virus particles (28).
gB is not essential for virus structure but is essential for virus
penetration into the host cell (5, 18, 21, 28). In addition, it is a
major immunological target for antibodies which can neutral-
ize virus infectivity (7, 23, 29).
The gB homolog of EBV (termed EBV gB or gpllO) is the
only gammaherpesvirus gB studied to date. Although EBV gB
shares colinear amino acid homology with HSV gB and has
similar structural motifs, it has markedly different biochemical
and biological properties (14, 15, 24). Thus, the glycosylation
on EBV gB exists only in an immature, high-mannose form
which is analogous to the precursor form of HSV gB (14).
Although EBV gB can be found in the nuclear and endoplas-
mic reticulum (ER) membranes, it is absent from the cell
surface and is not a component of the virus particle (14). As a
consequence, antibodies directed against gpllO do not neu-
tralize virus infectivity (14).
Since the EBV gB homolog is unusual among the herpesvi-
ruses, we considered that a study of MHV-68 gB (termed
MHV gB) would be important to explore the relatedness of
MHV-68 and EBV. In addition, since there is no easy means of
studying EBV replication in epithelial cells, we considered that
MHV gB would be a means of studying the properties of a
gammaherpesvirus gB in epithelial cells. In this paper we
describe the sequencing and characterization of the gB ho-
molog encoded by MHV-68 and show that it is extremely
similar to EBV gB (gpllO).
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MATERMILS AND METHODS
Virus and cells. Working stocks of MHV-68 clone g2.4 were
prepared in BHK-21 cells as described by Efstathiou et al. (11).
Purified virus was obtained by the use of discontinuous Ficoll
gradients as described by Blaskovic et al. (2). C127 (ATCC
CRL 1616) is a mouse epithelial cell line which was derived
from a mammary carcinoma (22) and was grown in Dulbecco's
modified Eagle's medium (Gibco/BRL, Paisley, United King-
dom) containing 10% fetal calf serum (Globepharm, Esher,
United Kingdom). The herpesvirus DNA replication inhibitors
phosphonoacetic acid and acyclovir were used as indicated at
concentrations of 100 pug/ml and 100 ,M, respectively.
DNA cloning and sequencing. All cloning techniques were
performed as described by Sambrook et al. (27). The MHV-68
BamHI 0 fragment was obtained from a genomic library
prepared from virion DNA in the phagemid vector pBluescript
KS(-) (Stratagene). The MHV-68 HindIII N fragment was
obtained from a pUC13 library described previously (11).
Small-scale plasmid DNA preparations were made by using
Wizard Minipreps (Promega), and double-stranded templates
were sequenced by using Sequenase v2.0 (U.S. Biochemicals).
Overlapping sequence of the complete open reading frame was
obtained on both strands by the use of oligonucleotide primers.
The sequence was assembled and analyzed by using the
Genetics Computer Group suite of computer programs (9).
Northern (RNA) blot analysis. Total cytoplasmic RNA was
extracted and analyzed exactly as described previously (32).
The probe used for MHV gB mRNA was the 707-bp BamHI-
Hincll subfragment of the BamHI 0 fragment (see Fig. 1)
corresponding to nucleotides 971 to 1678 of the sequence (see
Fig. 2). Molecular weight determinations were made in rela-
tion to an RNA ladder (Gibco/BRL).
Antisera. Monospecific anti-MHV gB immunoglobulin G
(IgG) was generated as follows. The same 707-bp BamHI-
HincII segment of the gB open reading frame used above for
Northern analysis and corresponding to gB amino acids 235 to
470 was cloned into the bacterial expression vector pGEX-1N
(Pharmacia). A glutathione-S-transferase-gB fusion protein
with a molecular weight of 50,000 was expressed in Eschenichia
coli and was purified on glutathione-Sepharose beads as spec-
ified by the manufacturer. Purified fusion protein was then
used to immunize rabbits in combination with Hunter's Titer-
max adjuvant (CytRX, Norcross, Ga.). Serum was prepared
from bleeds taken before and after immunization. IgG was
purified from sera by using a protein G-Sepharose column
(Pharmacia).
Rabbit anti-MHV-68 antiserum was prepared by using
MHV-68-infected rabbit kidney cells as described previously
(35).
Western immunoblot analysis. Cell and virus extracts (105
cells per track or equivalent) were solubilized in sample buffer,
electrophoresed through sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) gels (7.5% polyacryl-
amide), transferred to Immobilon-P membranes (Millipore),
and probed with antisera as described previously (33). Purified
anti-gB or preimmune IgG was used at a concentration of 4
,ug/ml, and anti-MHV-68 antiserum was used at a 1:500
dilution. Reactivity was detected by using alkaline phos-
phatase-conjugated swine anti-rabbit Igs (Dakopatts) at a
dilution of 1:1000 and developed by using Nitro Blue Tetrazo-
lium and 5-bromo-4-chloro-3-indolyl phosphate (Sigma fast;
Sigma).
Immunofluorescence analysis. Cells were grown and in-
fected on microscope slides and either fixed in acetone for 3
min at -70°C before being stained or stained live without
fixation but with the addition of azide throughout the staining
procedure. The staining procedures were as described previ-
ously (31, 32). Primary antibodies were used at a concentration
of 20 pug/ml for purified antibodies and 1:250 for anti-MHV-68
antibodies. Reactivity was detected by using fluorescein iso-
thiocyanate-conjugated swine anti-rabbit Igs (Dakopatts) at a
dilution of 1:30.
Radioimmunoprecipitation. Cells were metabolically la-
beled with [35S]cysteine, and proteins were immunoprecipi-
tated and analyzed by SDS-PAGE (7.5% polyacrylamide)
exactly as described previously (34). Purified IgG was used for
immunoprecipitation at a concentration of 20 ,ug/ml. Endogly-
cosidase H (endo H) digestion was performed with 3 mU of
recombinant enzyme (Boehringer) under the conditions de-
scribed by Gong and Kieff (14).
Virus neutralization assay. Serum dilutions varying between
1:10 and 1:320 were added to 100 PFU of MHV-68. In parallel
experiments, 5% rabbit complement (Cederlane) was added
after 30 min. The virus-serum combination was then used to
infect subconfluent C127 cells. After 5 days the monolayers
were fixed and plaques were counted. Each serum dilution was
assayed in quadruplicate on three separate occasions.
Nucleotide sequence accession number. The nucleotide se-
quence of MHV gB has been submitted to the GenBank
database and has been assigned accession number U08990.
RESULTS
Sequence of the MHV gB homolog. The location of the gB
homolog within the MHV-68 genome and a partial restriction
map of the HindIlI N fragment are shown in Fig. 1. The gB
homolog was identified from a DNA sequence obtained from
the end of the BamHI 0 fragment which showed similarity
with other herpesvirus gBs. This coding sequence was also in a
similar genomic position and ran in a similar direction to the
gB homolog genes of the gammaherpesviruses EBV and
herpesvirus saimiri (1, 24). From these data, it was predicted
that the complete open reading frame would be contained
within the HindIII N fragment. This fragment was therefore
subcloned by using a combination of the enzymes HindIII,
BamHI, and Hincll, and the sequence of the gene was
completed by using these subclones and gene-specific oligonu-
cleotide primers.
The DNA sequence of the gene, the predicted amino acid
sequence, and the sites of consensus motifs are shown in Fig. 2.
To the 5' end of the open reading frame there was a TATA box
which could act as a promoter element for the gene. It is of
interest that this sequence, although unusual for a TATA box,
is exactly the same in both EBV and herpesvirus saimiri. To the
3' end of the gene there is a consensus polyadenylation signal
sequence. By analogy with EBV, it was predicted that this was
the complete transcription unit and would produce an mRNA
of 2.8 kb.
Computer-assisted analysis (Table 1) showed that the pre-
dicted amino acid sequence of the complete open reading
frame had high homology with other herpesvirus gBs but in
particular with those of the gamma subgroup. Translation of
mRNAs usually occurs at the first available ATG codon.
However, analysis of the sequence around the first ATG
(nucleotide 269) by the method of Cavener and Ray (6)
indicated that this codon was in an extremely unfavorable
context for translational initiation. In contrast, the second
ATG (nucleotide 290) was in a favorable context. It would
therefore be predicted that translation would start at the latter
codon (amino acid 8), giving a potential precursor protein of
841 residues. Computer-assisted analysis of the predicted
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FIG. 1. Location and partial restriction enzyme map of MHV gB. The upper part of the figure is a restriction map of the unique portions of
the MHV-68 genome after digestion with BamHI and Hindlll as determined by Efstathiou et al. (11). Below this is a map of the HindIII fragment
which contains the gB open reading frame. The restriction sites shown are those which were used to subclone the fragment for sequencing
purposes. The solid bar below the map represents the extent and direction of the gB open reading frame. The line below this indicates the section
of the gene used as a probe on Northern blots and for expression in bacteria. A scale bar for the lower map is shown at the bottom right.
amino acid sequence by using the algorithms of Engelman et
al. (13) revealed two potential hydrophobic transmembrane
domains. The first of these (residues 8 to 29) displayed motifs
consistent with its being a signal peptide. The position of a
potential signal peptidase cleavage site, present at the end of
the underlined sequence in Fig. 2, was determined by the
method of von Heijne (38). Cleavage of the signal peptide
would yield a potential mature core protein of 821 residues and
with a molecular weight of 93,500. The second hydrophobic
domain (residues 709 to 747) was longer than required for a
transmembrane domain. However, it has been shown that only
a small portion of the potential transmembrane domain of
HSV gB acts as the membrane anchor (26). It would therefore
be predicted, by analogy with HSV, that the equivalent hydro-
phobic domain in the MHV gB homolog would span the
membrane once and act as an anchor region. Situated between
these two hydrophobic domains were nine potential sites for
the addition of N-linked glycosylation.
These data indicate that MHV-68 encodes a gene which is
highly homologous to herpesvirus gBs, in particular those of
gammaherpesviruses, not only in sequence but also in genome
location and putative structural motifs. As a consequence, the
protein will be referred to below as MHV gB.
Expression ofMHV gB mRNA by MHV-68-infected cells. A
primary site of MHV-68 productive replication in vivo is
epithelial cells. Therefore, to make these and subsequent
analyses as authentic as possible, we performed experiments
with mouse epithelial C127 cells. Since there were no pub-
lished data on the time course of MHV-68 gene expression,
cells were infected at high multiplicity of infection (10 PFU per
cell) and harvested for RNA extraction at various times
postinfection. In addition, infection was performed in the
presence of the herpesvirus DNA replication inhibitors phos-
phonoacetic acid and acyclovir. Extracted RNA was analyzed
by Northern blotting with the 707-bp BamHI-HincII fragment
(Fig. 1) of the MHV gB gene as a probe. The 28S rRNA
species was used as a control for RNA loading and integrity.
Figure 3 shows that a major gB-specific RNA of 2.8 kb
appeared at 8 h postinfection and was still present at 24 h
postinfection. This RNA was the correct size for the complete
gB transcription unit as predicted from analysis of the DNA
sequence. At 24 h postinfection an additional gB transcript of
8.6 kb was observed. Both transcripts were late viral RNAs,
since their production was blocked by the addition of phos-
phonoacetic acid or acyclovir during infection.
Expression ofMHV gB. To analyze MHV gB, we first raised
monospecific antibodies in rabbits by using a portion of gB
fused to glutathione-S-transferase as the antigen, as described
in Materials and Methods.
As for transcription, there were no published data on the
time course of expression of MHV-68 proteins, and so C127
cells were infected as above and harvested at various times
postinfection, and the expression of MHV gB was analyzed by
Western blotting with monospecific anti-MHV gB IgG as a
probe. The results (Fig. 4) showed that anti-MHV gB antibod-
ies recognized a single protein with a molecular weight of
FIG. 2. Sequence of the MHV gB open reading frame. The figure shows the sequence of part of the HindIII fragment which contains the gB
open reading frame. The DNA sequence is numbered from the upstream Hindlll site which is the boundary between the HindIII G and N
fragments (Fig. 1). The predicted amino acid sequence is shown above this. The sites of the consensus promoter and polyadenylation signal
sequences upstream and downstream of the open reading frame are shown in boldface type and are underlined. It was predicted that the putative
first 7 amino acids would not be translated, and so these are shown in lowercase type. The extents of the two hydrophobic domains are shown by
underlining, and the sites of potential N-linked glycosylation are shown in boldface type and by a triangle above the residues concerned.
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180 ATATCAAAAATCAATTGAGGGTATTAAAGACATCTATACAATGTTAAATTATCACTTGTACATTTGAACCGATTCAGCCAGTGTTGGATGTACCCTAC
5 v k s M R V A H L T N L L T L L C L L C H T H L Y V C Q P T T L R
280 AGTGAAAAGTATGAGAGTCGCCCACCTAACCAATCTCCTAACCCTTCTGTGTCTGCTGTGCCACACGCATCTCTACGTATGTCAGCCAACCACTCTGAGG
38 Q P S D M T P A Q D A P T E T P P P L S T N T N R G F E Y F R V C G
380 CAGCCATCAGACATGACCCCAGCCCAGGACGCTCCAACAGAGACTCCCCCACCCCTCTCAACTAACACTAACAGAGGATTTGAGTACTTTCGCGTGTGTG
72 V A A T G E T F R F D L D K T C P S T Q D K K H V E G I L L V Y K
480 GGGTGGCTGCCACGGGGGAGACCTTCAGGTTTGATTTAGACAAAACATGCCCCAGTACACAAGATAAGAAGCATGTGGAGGGCATCTTGCTCGTGTATAA
105 I N I V P Y I F K I R R Y R K I I T Q L T I W R G L T T S S V T G
580 GATCAACATCGTGCCCTACATCTTCAAAATCAGGAGATATAGAAAAATAATTACTCAACTGACCATCTGGCGAGGCCTAACCACTAGTTCAGTCACTGGT
138 K F E M A T Q A H E W E V G D F D S I Y Q C Y N S A T M V V N N V R
680 AAATTTGAAATGGCCACTCAGGCCCACGAGTGGGAAGTGGGCGACTTTGACAGCATCTATCAGTGCTACAATAGCGCCACCATGGTGGTAAACAACGTCA
172 Q V Y V D P D G V N K T V N I R P V D G L T G N I Q R Y F S Q P T
780 GACAGGTGTATGTGGACAGAGATGGGGTCAATAAAACTGTGAACATACGCCCTGTTGATGGTCTAACAGGGAATATCCAAAGATACTTTAGTCAGCCCAC
205 L Y S E P G W M P G F Y R V R T T V N C E I V D M V A R S M D P Y
880 CCTTTATTCAGAACCTGGTTGGATGCCTGGCTTTTATCGTGTTCGAACCACCGTTAACTGTGAAATTGTAGACATGGTGGCACGCTCCATGGATCCCTAT
238 N Y I A T A L G D S L E L S P F Q T F D N T S Q C T A P K R A D M R
980 AACTACATCGCTACCGCCCTGGGAGACAGCCTGGAGCTCTCCCCGTTTCAAACCTTTGACAACACCAGCCAGTGTACTGCGCCTAAGAGAGCTGATATGA
272 V R E V K N Y K F V D Y N N R G T A P A G Q S R T F L E T P S A T
1080 GGGTCAGGGAGGTCAAGPATTACAAGTTTGTAGATTATMTAACAGGGGAACTGCCCCCGCTGGACAAAGCAGGACCTTTCTAGAGACTCCCTCTGCCAC
305 Y S W K T A T R Q T A T C D L V H W K T F P R A I Q T A H E H S Y
1180 TTACTCCTGGAAAACAGCCACCAGACAAACTGCCACGTGCGACCTGGTGCACTGGAAAACATTCCCTCGCGCCATCCAAACTGCTCATGAACATAGCTAC
IV v
338 H F V A N E V T A T F N T P L T E V E N F T S T Y S C V S D Q I N K
1280 CATTTTGTGGCCAATGAAGTCACCGCCACCTTCAATACACCCCTGACTGAGGTAGAAAATTTCACCAGCACGTATAGCTGCGTCAGTGACCAGATCAATA
372 T I S E Y I Q K L N N S Y V A S G K T Q Y F K T D G N L Y L I W Q
1380 AGACCATCTCTGAATATATCCAAAAGTTGAACAACTCCTACGTGGCCAGTGGGAAAACACAGTATTTCAAGACTGATGGTAACCTGTACCTCATCTGGCA
405 P L E H P E I E D I D E D S D P E P T P A P P K S T R R K R E A A
1480 ACCACTCGAACATCCAGAGATTGAAGACATAGACGAGGACAGCGACCCAGAACCAACCCCCGCCCCACCAAAGTCCACAAGGAGAAAAAGAGAGGCAGCT
438 D N G N S T S E V S K G S E N P L I T A Q I Q F A Y D K L T T S V N
1580 GACAATGGAAACTCAACATCTGAGGTCTCAAAGGGCTCAGAAAATCCGCTCATTACGGCCCAAATTCAATTTGCCTATGACAAGCTGACCACCAGCGTCA
472 N V L E E L S R A W C R E Q V R D T L M W Y E L S K V N P T S V M
1680 ACAACGTGCTTGAGGAGTTGTCCAGGGCGTGGTGTAGAGAACAGGTCAGAGACACCCTCATGTGGTATGAGCTTAGCAAGGTCAACCCTACGAGTGTGAT
505 S A I Y G K P V A A R Y V G D A I S V T D C I Y V D Q S S V N I H
1780 GTCTGCCATTTATGGAAAGCCTGTCGCTGCCAGGTACGTGGGCGACGCCATATCTGTGACAGACTGTATCTATGTGGACCAAAGTTCAGTCAACATCCAC
538 Q S L R L Q H D K T T C Y S R P R V T F K F I N S T D P L T G Q L G
1880 CAGAGCTTGCGGCTGCAGCATGATAAAACCACCTGCTACTCGP.GACCTAGAGTCACCTTCAAATTTATAAACAGTACAGACCCGCTAACTGGCCAGTTGG
572 P R K E I I L S N T N I E T C K D E S E H Y F I V G E Y I Y Y Y K
1980 GTCCTAGAAAAGAAATTATCCTCTCCAACACAAACATAGAAACATGCAAGGATGAGAGTGAACACTACTTCATTGTGGGGGAATACATTTACTATTATAA
V V
605 N Y I F E E K L N L S S I A T L D T F I A L N I S F I E N I D F K
2080 AAATTACATTTTTGAAGPAAAGCTAAACCTCTCAAGCATCGCTACCCTAGACACATTTATAGCCCTCAATATCTCATTTATTGAAAATATCGACTTCAAA
638 T V E L Y S S T E R K L A S S V F D I E S M F R E Y N Y Y T Y S L A
2180 ACAGTAGAACTGTACTCCTCTACTGAAAGGAAACTCGCATCGAGCGTCTTTGATATAGAATCCATGTTTAGGGAATATAACTATTACACCTACAGCCTCG
672 G I K K D L D N T I D Y N R D R L V Q D L S D M M A D L G D I G R
2280 CGGGCATTAAGAAGGACCTAGACAACACCATCGACTACAATAGAGACAGACTGGTTCAGGACCTGTCAGACATGATGGCTGATCTGGGAGACATTGGAAG
705 S V V N V V S S V V T F F S S I V T G F I K F F T N P L G G I F I
2380 ATCTGTGGTGAATGTGGTCAGCTCGGTAGTCACATTTTTCAGTAGTATTGTGACAGGGTTCATTAAATTCTTTACCAACCCTCTAGGGGGAATATTCATT
738 L L I I G G I I F L V V V L N R R N S Q F H D A P I K M L Y P S V E
2480 CTCCTAATTATTGGTGGAATAATCTTCTTGGTGGTAGTCCTAAATAGAAGAAACTCACAGTTTCACGATGCACCCATCAAAATGCTGTACCCTTCTGTTG
772 N Y A A R Q A P P P Y S A S P P A I D K E E I K R I L L G M H Q V
2580 AAAACTACGCTGCCAGACAGGCGCCACCTCCCTATAGCGCATCACCTCCAGCTATAGACAAAGAGGAAATTAAGCGCATACTTTTGGGCATGCATCAGGT
805 H Q E E K E A Q K Q L T N S G P T L W Q K A T G F L R N R R K G Y
2680 ACACCAGGAAGAAAAGGPAGCACAGAAACAACTAACCAACTCTGGCCCTACTTTGTGGCAGAAAGCCACAGGATTCCTTAGAAATCGCCGGAAGGGATAC
838 S Q L P L E D E S T S L
2780 AGCCAACTTCCTCTGGAAGATGAATCAACTTC-CTCTAGTGGCCACCCCATGACTCAGACACTTTAAAAACTAATACTTTGAATAATAAACTGGTTTCTG
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TABLE 1. Comparison of gB homologs from representative
herpesviruses in relation to MHV gB
Subgroupa Virusb No. of codons % Identity' % Similarity'
a HSV-1 904 26 46
HSV-2 904 28 48
VZV 868 25 46
1a CMV 906 31 50
'y EBV 857 42 60
HVS 808 49 67
MHV-68 841 100 100
a Individual herpesvirus subgroups.
b Abbreviations: HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex
virus type 2; VZV, varicella-zoster virus; CMV, cytomegalovirus; HVS, herpes-
virus saimiri.
'Amino acid sequences were compared by using the GAP option of the
Genetics Computer Group software package (9) with the gap weight and length
parameters set at 3.0 and 0.1, respectively. Amino acid sequence identity and
similarity relative to MHV gB, based on conservative substitutions (8), are given
for homologous protein sequences.
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FIG. 4. Western blot analysis of MHV gB expression. Cells were
infected with MHV-68 at 10 PFU per cell and then harvested at 0, 4,
8, 24, and 48 h postinfection as indicated above the lanes. Cell extracts
were analyzed by Western blotting with anti-gB antibodies as a probe.
The positions of protein molecular weight standards (in thousands) are
shown on the left, as is the position of the gB band.
105,000 in MHV-68-infected cells. An identical blot probed
with pre-immune IgG was entirely negative, and thus the
antibody was specific. MHV gB was not detected in infected
cells until 24 h postinfection and was still present at a slightly
lower level at 48 h postinfection. Thus, the time course of
MHV gB expression was consistent with but delayed relative to
RNA expression, indicating that gB was produced late in the
virus productive replication cycle.
Nature of glycosylation of MHV gB. The predicted molecu-
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FIG. 3. Northern blot analysis of MHV gB transcription. Mouse
epithelial (C127) cells were infected with 10 PFU of MHV-68 per cell
and harvested at 0, 4, 8 and 24 h postinfection as indicated above the
lanes. In addition, cells were infected in the presence of phosphono-
acetic acid (PAA) or acyclovir (ACV) and harvested at 24 h postin-
fection. Cytoplasmic RNA was extracted from the cells and analyzed
by Northern blotting with part of the gB open reading frame (Fig. 1)
as a probe. An autoradiogram of the blot is shown in the upper panel,
with the positions of an RNA size ladder (in kilobases) to the left. The
sizes of the major gB-specific RNAs (in kilobases) are indicated on the
right. The lower panel shows an ethidium bromide-stained image of
28S rRNA as a control for RNA loading and integrity.
lar weight of mature core MHV gB was 93,500. Since the
predicted amino acid sequence contained nine potential sites
for N-linked glycosylation, it seemed likely that the protein
with a molecular weight of 105,000 expressed in MHV-infected
cells was a glycoprotein. In addition, like EBV gB and unlike
HSV gB, which has a precursor form and a mature form with
distinct molecular weights, MHV gB appeared as a single-
molecular-weight species. This suggested that MHV gB might
be like EBV gB and contain only immature, high-mannose,
N-linked glycosylation (14).
Initial radioimmunoprecipitation studies with [14C]glu-
cosamine-labeled, infected-cell extracts revealed that MHV gB
was glycosylated (data not shown). To investigate the nature of
the glycosylation, we studied the effect of endo H on MHV gB.
This enzyme will digest only N-linked glycans of the high-
mannose type, leaving fully processed glycosylation intact.
Cells were metabolically labeled between 16 and 20 h postin-
fection with [35S]cysteine, a time at which MHV gB synthesis
was occurring as predicted from the Northern and Western
analyses. Radiolabeled proteins were immunoprecipitated with
either anti-MHV gB or preimmune IgG, and a portion of the
immunoprecipitate was treated with endo H.
The results (Fig. 5) showed that no labeled proteins were
precipitated from either mock-infected cells with anti-MHV
gB or MHV-68-infected cells with preimmune IgG. Anti-MHV
gB immunoprecipitated a protein with a molecular weight of
105,000, corresponding to MHV gB, from MHV-68-infected
cells. All of this protein detected was reduced in molecular
weight to 92,000 after digestion with endo H. The size of the
endo H-digested protein is similar to the predicted molecular
weight of core MHV gB. An endo H-resistant protein with a
molecular weight of 46,000 was also precipitated specifically by
anti-MHV gB IgG from MHV-68-infected cells. The nature of
this band is not known; however, the results of [14C]glu-
cosamine labeling and of pulse-chase experiments revealed
that it was nonglycosylated and cotranslational with (and
therefore not a breakdown product of) MHV gB.
Thus, MHV gB with a molecular weight of 105,000 is a
glycoprotein and resembles EBV gB (gpllO) in that it contains
only high-mannose carbohydrate.
Intracellular localization of MHV gB. Since the possession
of endo H-sensitive carbohydrate is characteristic of proteins
trapped in the ER (20), we next analyzed the intracellular
localization of MHV gB. Cells were grown on slides and then
infected with MHV-68. They were then either fixed and
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FIG. 5. Endo H sensitivity of MHV gB. Cells were either mock
infected (lane labeled C127) or infected with MHV-68 at 10 PFU per
cell for 16 h (lanes MHV) and then metabolically labeled with
[35S]cysteine. Proteins were immunoprecipitated with either preim-
mune IgG (indicated by -) or anti-gB IgG (indicated by +). An
aliquot of the proteins immunoprecipitated by anti-gB was exposed to
endo H (indicated by +). The positions of molecular weight markers
(in thousands) are shown on the left.
A 2 W ' ' 'i7e ,$ .
<s V me 5 07 r -- F,@¢.
.* w. .s .wAr r wi ..6wW St ; >S i 6 A b z . .K ' R .s >,. h g
-4 ^1ls t- .x
E 4 F k ,.v. f5 ., .e .d .
_ i
... tSk ';
C D
E F
4f..' 4
.Yv; I
%.
permeabilized by using acetone prior to immunofluorescence
analysis or stained live without being fixed.
The results are shown in Fig. 6. Figure 6C and E shows that
there was no immunofluorescent staining after acetone fixation
with either the anti-MHV gB IgG on mock-infected C127 cells
or pre-immune IgG on MHV-68-infected cells. However, when
anti-MHV gB IgG was reacted with acetone-fixed MHV-68-
infected cells (Fig. 6A), there was intense staining which was
localized to diffuse patches in the cytoplasm and in the nuclear
rim. Such a staining pattern is reminiscent of proteins which
are localized in the ER and nuclear envelope (17). In contrast
(Fig. 6G), no immunofluorescence was seen when anti-MHV
gB was reacted with live, unfixed MHV-68-infected cells. A
polyclonal rabbit anti-MHV-68 antiserum, used as a positive
control, showed intense surface immunofluorescence when
reacted with unfixed, MHV-68-infected cells (Fig. 6I and J) but
no reactivity with mock-infected cells (Fig. 6K and L).
Thus, immunoreactive MHV-68 proteins were reaching the
surface of infected cells. In contrast, and in agreement with the
biochemical data, MHV gB did not appear to be expressed at
the infected-cell surface but instead gave a pattern of staining
which was consistent with localization in the nuclear envelope
and ER.
gB is not detected in MHV-68 particles. On the basis of both
biochemical and immunofluorescence data, MHV gB was
absent from the surface of infected cells. We therefore deter-
mined whether the molecule was incorporated into MHV-68
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FIG. 6. Immunofluorescence analysis of MHV-68-infected cells. C127 cells were either mock infected (E, F, K, and L) or infected with 10 PFU
of MHV-68 per cell for 24 h (A to D and G to J). Slides were then either, fixed with acetone (A to F) or left untreated (G to L) before the
immunofluorescence staining procedure. Cells were stained with either preimmune IgG (C and D), anti-gB IgG (A, B, and E to H), or
anti-MHV-68 antiserum (I to L). Immunofluorescence was then visualized by using a UV microscope (A, C, E, G, I, and K). The same field, shown
to the right of the UV image, was visualized by phase-contrast microscopy (B, D, F, H, J, and L.). All panels are shown at the same magnification.
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FIG. 7. Western blot analysis of MHV-68-infected cells and
MHV-68 particles. Mock-infected cell extracts (lanes C127) and
MHV-68-infected cell extracts (lanes C127 + MHV) were analyzed
alongside an extract of purified virions from an equivalent number of
cells (lanes VIRION). Identical blots were probed with either an
anti-MHV-68 serum (A) or anti-gB IgG (B). The positions of molec-
ular weight markers (in thousands) and the gB band are indicated on
the left.
particles. To do this, we infected C127 cells and purified virus
particles away from cellular debris. Virus particles were ana-
lyzed by Western blotting alongside MHV-68-infected and
mock-infected cells. Identical blots were probed with either a
polyclonal anti-MHV-68 antiserum or anti-gB IgG.
The results (Fig. 7) showed that anti-MHV antiserum iden-
tified a number of immunoreactive proteins in MHV-68-
infected cells. A subset of these were also detected in MHV-68
particles, with the bands being of comparable intensity to the
equivalent bands in MHV-68-infected cells, indicating the
presence of similar amounts of virus proteins in the two
samples. The specificity of the anti-MHV-68 antiserum was
shown by its lack of reaction with mock-infected C127 cells. As
in previous experiments, anti-gB IgG identified a major gB
band, with a molecular weight of 105,000, produced by MHV-
68-infected cells. However, this band was not detected in
purified MHV-68 particles. Again, the specificity of the anti-gB
IgG was shown by its lack of reaction with mock-infected cells.
Thus, these data support the thesis that, like EBV (14), the
MHV gB homolog is either absent from virus particles or
present at a level manyfold lower than in infected cells.
Anti-gB antibodies do not neutralize virus infectivity. The
data presented above suggest that MHV gB is not present in
virions. However, it is still possible that a low level of gB is
present on MHV-68 particles and thus exerts some influence
on virus infectivity. We therefore assayed the ability of the
polyclonal anti-gB reagent to neutralize MHV-68. The anti-gB
IgG had been raised against a portion of the molecule which,
by analogy with other herpesvirus gBs (7, 23, 29), should form
a significant portion of an external domain and contain neu-
tralizing epitopes. We therefore used this reagent in a conven-
tional plaque reduction assay with preimmune IgG as a
background control and polyclonal anti-MHV-68 as a positive
control. The results of three separate experiments demon-
strated that anti-gB IgG exhibited no neutralizing activity over
background, even in the presence of complement. In contrast,
in the same experiments, the polyclonal anti-MHV-68 anti-
serum exhibited vigorous virus neutralization, giving >95%
reduction in plaque number at all concentrations tested.
These results therefore corroborate the biochemical data
and suggest that MHV gB, even if present on the virion at low
levels, does not influence the entry of MHV-68 into cells.
DISCUSSION
We have identified, sequenced, and characterized the MHV
gB homolog. The open reading frame was contained within the
HindIII N fragment of the viral genome, and its predicted
amino acid sequence showed strong homology with those of
other gB molecules. Transcriptional analysis of the MHV gB
gene demonstrated that it was a late gene with a major mRNA
of 2.8 kb. Biochemical studies revealed that the MHV gB
molecule was a glycoprotein with a molecular weight of
105,000, which contained only high-mannose, N-linked glycans.
In addition, the protein was localized to the infected-cell
cytoplasm and nuclear margins but was not detected either at
the cell surface or in virions. Finally, biological data showed
that antibodies to gB did not mediate virus neutralization.
All herpesviruses contain a homolog of the HSV gB, and it
is the protein which shows most conservation among viruses.
Evidence supporting the thesis that the gene sequenced here
was the MHV gB homolog is as follows. First, the deduced
amino acid structure had extensive homology with other gB
sequences. Second, it is in a similar location in the virus
genome and reads in the same direction as the EBV and
herpesvirus saimiri gB open reading frames. Third, sequences
from either side of the gene revealed that it is contained within
a gene block conserved throughout herpesviruses. Conse-
quently, this protein was termed MHV gB.
Although it is formally possible that there are parts of the
gene which are derived by splicing, this is considered unlikely
for several reasons. First, other herpesviruses gB genes are not
spliced. Second, there are consensus start and stop transla-
tional signals either side of the open reading frame, which
would be predicted to produce a mRNA the same size as the
major transcript seen by northern blotting. Third, the size of
the protein seen after digestion of the carbohydrate with endo
H was the same as that of the predicted core protein.
The major MHV gB-specific 2.8-kb RNA was produced at 8
h postinfection, but at 24 h postinfection another RNA, of 8.6
kb, was observed. Both these are late transcripts. The smaller
RNA probably represents the complete transcription unit
described in the sequence and containing the gB open reading
frame. The nature and significance of the larger transcript are
unknown but indicate differences in the pattern of MHV-68
gene transcription between times around the initiation ofDNA
replication and at later times postinfection.
The molecular weight of MHV gB as determined by both
Western analysis and immunoprecipitation was 105,000. How-
ever, an additional protein, with a molecular weight of 46,000,
was observed after immunoprecipitation. The nature of this
band is unclear, but since it was not seen by Western analysis,
it probably represents a protein which is coprecipitated with
the full-length MHV gB. Pulse-chase analysis suggested that it
was not a breakdown product of gB, and thus it is likely that the
smaller polypeptide is a novel cellular or viral band.
Possession of endo H-resistant carbohydrate is a feature of
proteins which remain in the ER and do not reach the Golgi or
cell surface (20, 26). The endo H sensitivity of MHV gB and
the immunofluorescence data indicate that MHV gB is like the
HSV gB precursor (19, 39) and EBV gB (14) and is present
only in the ER and nuclear membranes. Thus, MHV gB must
either lack a signal necessary for Golgi transport, possess its
own signal for ER retention, or be targeted to the ER by a
molecular chaperone. Consistent with the above is the fact that
MHV gB was not detected in virus particles. It is possible that
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the MHV gB was present in virions but at a considerably
reduced level from that seen in infected cells, and further
immunoelectron-microscopic studies are required to prove this
definitively. However, if gB was present on MHV-68 particles
at a low level, it did not appear to play a role in virus infection
like the gBs of the alpha- and betaherpesviruses, since anti-
MHV gB antibodies were nonneutralizing. Thus, like EBV gB,
the function of MHV gB is unclear, but it may have some role
in virus assembly or egress.
Initially, MHV-68 was classified as an alphaherpesvirus
because of its ability to replicate in monolayer cultures of
nonlymphoid origin (2). However, subsequent genetic and
biological analyses have shown that MHV-68 is in fact more
akin to the gammaherpesvirus subgroup (10, 35-37). The EBV
gB (gpl10), which to date is the only gammaherpesvirus gB to
have been studied, is somewhat unusual compared with the
gBs of both alpha- and betaherpesviruses. Our results demon-
strate that MHV gB is like EBV gB in many respects. This
strengthens the basis for the classification of MHV as a
gammaherpesvirus and provides another demonstration of the
relatedness of MHV and EBV.
There is no good system for the study of the EBV lytic cycle.
In particular, there is no easy means of studying EBV replica-
tion in epithelial cells. Thus, all the studies on EBV gB have
been done in B-cell lines which carry latent EBV and have
been chemically induced into productive virus replication. The
results obtained here with MHV and epithelial cells suggest
that the discrepancies observed between EBV gB and other
herpesviruses may be due to differences between herpesvirus
subgroups and not to the EBV studies being performed in B
cells.
Our results therefore indicate that MHV-68 may be a model
for the study of various aspects of EBV and gammaherpesvirus
productive replication in epithelial cells in vitro. In addition,
MHV-68 may be a good means of studying the function in
relation to the influence in pathogenesis and the immune
response to gammaherpesvirus gBs in vivo.
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